Optimizing endoscopic detection of precancerous gastric conditions: Single-center prospective study

Abstract

Background and study aims

Chronic atrophic gastritis is an asymptomatic precancerous condition that can progress to extensive atrophy and/or intestinal metaplasia (IM), referred to as advanced stage of atrophic gastritis (ASAG). ASAG is a common condition with a variable prevalence worldwide reaching 45%. Narrow-band imaging (NBI) already has an established role in improving endoscopic detection of atrophy and IM. Considering the heterogeneous hospital population, this study aimed to assess the ASAG detection rate with NBI-guided biopsies compared with conventional Sydney protocol, in a European cosmopolitan city hospital.

Patients and methods

This was a prospective, single-center, bi-phasic study conducted between October 2023 and March 2024, comparing ASAG detection rates using conventional Sydney protocol with optional NBI use, defined as phase 1, versus systematic NBI-guided biopsies in phase 2.

Results

Of 495 eligible patients, 435 with similar demographics were included in both phases (87.8%). ASAG was detected in three patients using conventional Sydney protocol (1.43%) compared with eight patients (3.56%) using systematic NBI-guided biopsies (P = 0.269). Furthermore, systematic NBI-guided biopsies were associated with increased detection rates for atrophy and IM (P = 0.223 and P = 0.502, respectively). Suspicion-free NBI use correlated with increased likelihood of ASAG detection (odds ratio 16.99, 95% confidence interval 2.30–213.73). Age ≥ 50 years was a significant risk factor associated with ASAG.

Conclusions

Despite the diverse hospital population, ASAG prevalence remained low. A numerical increase in ASAG detection rate was observed with systematic NBI use compared with optional NBI use. Overall, systematic NBI-guided biopsies appear to be associated with increased rates of detection of ASAG, atrophy, and IM.

Keywords

Endoscopy Upper GI Tract - Precancerous conditions & cancerous lesions (displasia and cancer) stomach - Diagnosis and imaging (inc chromoendoscopy, NBI, iSCAN, FICE, CLE)

Publikationsverlauf

Eingereicht: 03. September 2024

Angenommen nach Revision: 24. Februar 2025

Accepted Manuscript online:
12. März 2025

Artikel online veröffentlicht:
04. April 2025

• References

• 1 Bray F, Laversanne M, Sung H. et al. Global Cancer Statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024; 74: 229-263
• 2 Pimentel-Nunes P, Libânio D, Marcos-Pinto R. et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy 2019; 51: 365-388
• 3 Marques-Silva L, Areia M, Elvas L. et al. Prevalence of gastric precancerous conditions: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2014; 26: 378-387
• 4 Pimentel-Nunes P, Libânio D, Lage J. et al. A multicenter prospective study of the real-time use of narrow-band imaging in the diagnosis of premalignant gastric conditions and lesions. Endoscopy 2016; 48: 723-730
• 5 Shah SC, Piazuelo MB, Kuipers EJ. et al. AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review. Gastroenterology 2021; 161: 1325-1332.e7
• 6 Buxbaum JL, Hormozdi D, Dinis-Ribeiro M. et al. Narrow-band imaging versus white light versus mapping biopsy for gastric intestinal metaplasia: a prospective blinded trial. Gastrointest Endosc 2017; 86: 857-865
• 7 Song YH, Xu LD, Xing MX. et al. Comparison of white-light endoscopy, optical-enhanced and acetic-acid magnifying endoscopy for detecting gastric intestinal metaplasia: A randomized trial. World J Clin Cases 2021; 9: 3895-907
• 8 Barbeiro S, Libânio D, Castro R. et al. Narrow-band imaging: Clinical application in gastrointestinal endoscopy. Port J Gastroenterol 2019; 26: 40-53
• 9 Young E, Philpott H, Singh R. Endoscopic diagnosis and treatment of gastric dysplasia and early cancer: Current evidence and what the future may hold. World J Gastroenterol 2021; 27: 5126-5151
• 10 Nieuwenburg SAV, Waddingham WW, Graham D. et al. Accuracy of endoscopic staging and targeted biopsies for routine gastric intestinal metaplasia and gastric atrophy evaluation study protocol of a prospective, cohort study: the estimate study. BMJ Open 2019; 9
• 11 Duez L, Gkolfakis P, Bastide M. et al. Premedication with simethicone for improving the quality of gastric mucosal visualization: a double-blind randomized controlled trial. Endosc Int Open 2022; 10: E1343-E1349
• 12 Cho JH, Jeon SR, Jin SY. Clinical applicability of gastroscopy with narrow-band imaging for the diagnosis of Helicobacter pylori gastritis, precancerous gastric lesion, and neoplasia. World J Clin Cases 2020; 8: 2902-2916
• 13 National Institute on Alcohol Abuse and Alcoholism. Drinking levels defined. https://www.niaaa.nih.gov/alcohol-health/overview-alcohol-consumption/moderate-binge-drinking
• 14 Hooi JKY, Lai WY, Ng WK. et al. Global prevalence of Helicobacter pylori infection: Systematic review and meta-analysis. Gastroenterology 2017; 153: 420-429
• 15 De Vries AC, Meijer GA, Looman CWN. et al. Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands. Gut 2007; 56: 1665-1670
• 16 Lahner E, Zagari RM, Zullo A. et al. Chronic atrophic gastritis: Natural history, diagnosis and therapeutic management. A position paper by the Italian Society of Hospital Gastroenterologists and Digestive Endoscopists [AIGO], the Italian Society of Digestive Endoscopy [SIED], the Italian Society of Gastroenterology [SIGE], and the Italian Society of Internal Medicine [SIMI]. Dig Liver Dis 2019; 51: 1621-1632
• 17 Delgado-Guillena PG, Barreiro E, Tejedor J. et al. Gastric cancer risk assessment of gastritis in clinical practice by using the histological information recommended by the updated Sydney system: The OLGIMA system. Endoscopy 2024; 56: S57-S58
• 18 Dias-Silva D, Pimentel-Nunes P, Magalhães J. et al. The learning curve for narrow-band imaging in the diagnosis of precancerous gastric lesions by using Web-based video. Gastrointest Endosc 2014; 79: 910-920
• 19 Yin Y, Liang H, Wei N. et al. Prevalence of chronic atrophic gastritis worldwide from 2010 to 2020: an updated systematic review and meta-analysis. Ann Palliat Med 2022; 11: 3697-3703
• 20 Nakamura M, Haruma K, Kamada T. et al. Duodenogastric reflux is associated with antral metaplastic gastritis. Gastrointest Endosc 2001; 53: 53-59
• 21 Li J, Perez Perez GI. Is there a role for the non-Helicobacter pylori bacteria in the risk of developing gastric cancer?. Int J Mol Sci 2018; 19: 1353
• 22 Lee SP, Sung IK, Kim JH. et al. Factors impacting patient cooperation during elective gastroscopy. Korean J Intern Med 2017; 32: 819-826